Carcinoma, Transitional Cell research hub

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

This study is testing a new medicine, vepugratinib, for advanced or spread bladder cancer. It will be given with two other drugs, enfortumab vedotin and pembrolizumab, to see if it's safe and helps. It’s compared to a dummy medicine (placebo).